therapeutic vaccines

Layoffs
Biotech

IO lays off 50% after FDA derails cancer vaccine approval plan

IO Biotech has resorted to halving its workforce after the FDA knocked back its plans to seek approval for its cancer vaccine.
James Waldron Sep 29, 2025 8:55am
investment money shot vaccine pharma dollar

Gilead pays partner Hookipa $10M for HBV, HIV vaccines

May 22, 2025 10:10am